% Expired Patents = 38.5

EPO Patents = 2

Forward Citations = 76

Loading Chart...

4 inventors (with patents filed for the assignee):

Francis J Martin (12 out of 55 patents)

Anthony A Boiarski (9 out of 13 patents)

Ling-Ling Kang (3 out of 5 patents)

4. Gregory Alan Watkins (1 out of 1 patent)

13 patents: Sort by Forward Citations

1. 10974036 - Implantable device for long-term delivery of drugs (2021-04-13),

2. 10391288 - Implantable device for long-term delivery of drugs (2019-08-27),

3. 10137081 - Device and method for sustained release of antipsychotic medications (2018-11-27),

4. 9561352 - Implantable device for long-term delivery of drugs (2017-02-07),

5. 9433574 - Microfabricated nanopore device for sustained release of therapeutic agent (2016-09-06),

6. 9433573 - Microfabricated nanopore device for sustained release of therapeutic agent (2016-09-06),

7. 9271926 - Microfabricated nanopore device for sustained release of therapeutic agent (2016-03-01),

8. 9066876 - Microfabricated nanopore device for sustained release of therapeutic agent (2015-06-30),

9. 9066875 - Microfabricated nanopore device for sustained release of therapeutic agent (2015-06-30),

10. 9005650 - Microfabricated nanopore device for sustained release of therapeutic agent (2015-04-14),

11. 8986727 - Microfabricated nanopore device for sustained release of therapeutic agent (2015-03-24),

12. 8603076 - Microfabricated nanopore device for sustained release of therapeutic agent (2013-12-10),

13. 7955614 - Microfabricated nanopore device for sustained release of therapeutic agent (2011-06-07),

Company Overview

Delpor, Inc. is a biotechnology company based in Brisbane, California, specializing in the development of innovative drug delivery systems. The company focuses on enhancing the efficacy and safety of therapeutic agents through its proprietary technologies, which aim to improve patient outcomes. Delpor's research primarily revolves around advanced formulations and delivery mechanisms, addressing critical needs in the pharmaceutical industry. Their commitment to innovation positions them as a key player in the evolving landscape of drug delivery solutions.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

13 Patents

#10 in Brisbane, CA

#5,656 in California

#23,838 in US

#45,039 in the World

Brisbane, CA, United States of America

Delpor, Inc.

Forward Citations = 76

4 inventors:

Francis J Martin (12 out of 55 patents)

Anthony A Boiarski (9 out of 13 patents)

Ling-Ling Kang (3 out of 5 patents)

4. Gregory Alan Watkins (1 out of 1 patent)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Delpor, Inc.. Retrieved from https://idiyas.com/company/delpor

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

2 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]